dual agonist therapy

Tirzepatide vs Semaglutide: The Science Behind the Weight Loss Gap

by

A major clinical trial found that tirzepatide produced greater average weight loss than semaglutide over 72 weeks. Here’s what researchers believe explains the difference between these two leading obesity medications.

Why Zepbound Users Lose More Weight Than Wegovy Users

by

New clinical trial data show that Zepbound users lost significantly more weight than Wegovy users over 72 weeks. Here’s how tirzepatide and semaglutide compare in effectiveness, side effects, cardiovascular benefits, and obesity treatment outcomes.